Literature DB >> 16141860

Long-term juxtafoveal retinal telangiectasia.

Robert C Watzke1, Michael L Klein, James C Folk, Samuel G Farmer, Richard S Munsen, Robert J Champfer, K R Sletten.   

Abstract

PURPOSE: To determine the long-term natural history of idiopathic juxtafoveal telangiectasia (IJRT).
METHODS: Record review in 2 university-based and 2 private vitreoretinal practices sought patients with IJRT documented by color photographs and fluorescein angiograms (FAs) during the period January 1, 1980, to December 31, 1993. Patients then had repeated examinations and FAs.
RESULTS: Twenty patients with IJRT in 32 eyes had follow-up examinations. Fifteen patients had color photographs and FAs, and one had color photographs alone. Follow-up varied from 10 years to 21 years (average, 15 years). Six eyes were treated by laser photocoagulation at onset. Twenty-four of the 26 untreated eyes lost vision as measured by Snellen testing. Visual loss and morphologic progression depended on IJRT type. Six of 8 untreated eyes with type IA IJRT lost vision by >/ or = 3 lines (Snellen), 4 to 20/70 or worse. Vision loss was caused by progressive telangiectatic changes and intraretinal edema. Fifteen of 20 initially untreated eyes with type IIA IJRT developed either central retinal pigment epithelium membranes or subretinal neovascularization with loss of vision to 20/80 or less.
CONCLUSION: IJRT prognosis depends on type and clinical features. Long-term prognosis for central vision is poor.

Entities:  

Mesh:

Year:  2005        PMID: 16141860     DOI: 10.1097/00006982-200509000-00007

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  13 in total

1.  Treatment of nonneovascular idiopathic macular telangiectasia type 2 with intravitreal ranibizumab: results of a phase II clinical trial.

Authors:  Brian C Toy; Euna Koo; Catherine Cukras; Catherine B Meyerle; Emily Y Chew; Wai T Wong
Journal:  Retina       Date:  2012-05       Impact factor: 4.256

2.  Diagnosis of subretinal neovascularization associated with idiopathic juxtafoveal retinal telangiectasia - fluorescein angiography versus spectral-domain optical coherence tomography.

Authors:  Jay Chhablani; Kopal Mithal; Harsha Rao; Raja Narayanan
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-10-23       Impact factor: 3.117

3.  Subretinal neovascular membrane associated with type 2a idiopathic juxtafoveolar telangiectasis in pseudoxanthoma elasticum.

Authors:  Maurizio Battaglia Parodi; Pierluigi Iacono; Giuseppe Ravalico
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-09-19       Impact factor: 3.117

4.  Long-term course in type 2 idiopathic macular telangiectasia.

Authors:  Tobias Meyer-ter-Vehn; Sina Herzog; Marc Schargus; Winfried Göbel; Rainer Guthoff
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-04-25       Impact factor: 3.117

5.  Idiopathic juxtafoveolar retinal telangiectasis: a current review.

Authors:  Sawsan R Nowilaty; Hanan N Al-Shamsi; Wajeeha Al-Khars
Journal:  Middle East Afr J Ophthalmol       Date:  2010-07

Review 6.  Macular telangiectasia type 2.

Authors:  Peter Charbel Issa; Mark C Gillies; Emily Y Chew; Alan C Bird; Tjebo F C Heeren; Tunde Peto; Frank G Holz; Hendrik P N Scholl
Journal:  Prog Retin Eye Res       Date:  2012-12-03       Impact factor: 21.198

7.  Indocyanine-green-mediated photothrombosis (IMP) with intravitreal triamcinolone acetonide for macular edema secondary to group 2A idiopathic parafoveal telangiectasis without choroidal neovascularization: a pilot study.

Authors:  J Fernando Arevalo; Juan G Sanchez; Reinaldo A Garcia; Lihteh Wu; Maria H Berrocal; Francisco J Rodriguez; Alvaro Rodríguez; Liliana Andrea Novoa; Rafael Garcia-Amaris
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-07-10       Impact factor: 3.117

8.  [Therapeutic approaches for macular telangiectasia type 2: status quo and perspectives].

Authors:  F G Holz; T F C Heeren; E Krüger; M Zeimer; D Pauleikhoff; P Charbel Issa
Journal:  Ophthalmologe       Date:  2014-09       Impact factor: 1.059

9.  Clinical features of idiopathic juxtafoveal telangiectasis in Koreans.

Authors:  Seung Woo Lee; Sung Min Kim; Yun Taek Kim; Se Woong Kang
Journal:  Korean J Ophthalmol       Date:  2011-07-22

10.  Long term follow-up of visual acuity and incidence of subretinal neovascularization in Mactel Type 2 in 82 Eyes.

Authors:  Kerul Marsonia; Kedarisetti Kiran Chandra; M Hasnat Ali; Jay Chhablani; Raja Narayanan
Journal:  Semin Ophthalmol       Date:  2021-05-23       Impact factor: 2.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.